Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Merck KGaA
  6. News
  7. Summary
    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Merck KGaA to Invest More Than $3.5 Billion in Electronics Business

09/20/2021 | 03:30am EDT

By Joshua Kirby

Merck KGaA said Monday that it will invest in its electronics business over the coming years, as it looks to capitalize on global growth in demand for semiconductor and display materials.

The German company plans to invest more than 3 billion euros ($3.52 billion) in its electronics division by the end of 2025. Money will go into research and development, as well as into capital expenditure on long-term fixed assets, Merck KGaA said.

The company aims for compound annual growth of between 3% and 6% to 2025 in the business, which makes memory chips and processors.

Write to Joshua Kirby at joshua.kirby@wsj.com; @joshualeokirby

(END) Dow Jones Newswires

09-20-21 0329ET

All news about MERCK KGAA
10/14MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German Securities..
EQ
10/14MERCK : EMD Serono, Inc. - New Real-World MAVENCLAD Data Show Sustained Effectiveness and ..
AQ
10/13Merck KGaA's Multiple Sclerosis Treatment Drug Shows Improved Quality Of Life In Study
MT
10/13MERCK KGAA : JP Morgan reaffirms its Buy rating
MD
10/12MERCK : Opens Second Facility In California, US, With $115 Million Investment
MT
10/12MERCK KGAA : Bernstein reiterates its Neutral rating
MD
10/12MERCK : MilliporeSigma Announces Completion of New Viral Vector Contract Development Manuf..
AQ
10/07MERCK KGAA : Gets a Neutral rating from NorldLB
MD
10/06MARKETMIND : Hunker down, it's going to be one of those days
RE
10/05CORRECTION : Merck KGaA Agrees to License CRISPR Technology to Genomics Group Cellecta
MT
More news
Analyst Recommendations on MERCK KGAA
More recommendations
Financials
Sales 2021 19 375 M 22 475 M 22 475 M
Net income 2021 2 765 M 3 208 M 3 208 M
Net Debt 2021 8 932 M 10 361 M 10 361 M
P/E ratio 2021 30,0x
Yield 2021 0,80%
Capitalization 83 630 M 97 018 M 97 010 M
EV / Sales 2021 4,78x
EV / Sales 2022 4,38x
Nbr of Employees 58 408
Free-Float 29,7%
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | MarketScreener
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 192,35 €
Average target price 198,21 €
Spread / Average Target 3,05%
EPS Revisions
Managers and Directors
BelÚn Garijo Lˇpez Chairman-Executive Board & CEO
Marcus Kuhnert Chief Financial Officer
Wolfgang Heinz BŘchele Chairman-Supervisory Board
Maria Rivas Chief Medical Officer & Senior Vice President
Laura Matz Chief Science & Technology Officer
Sector and Competitors